Literature DB >> 26339454

Podoplanin increases migration and angiogenesis in malignant glioma.

Stefan J Grau1, Fabian Trillsch2, Joerg-Christian Tonn3, Roland H Goldbrunner2, Elfriede Noessner4, Peter J Nelson5, Irene von Luettichau6.   

Abstract

Expression of podoplanin in glial brain tumors is grade dependent. While serving as a marker for tumor progression and modulating invasion in various neoplasms, little is known about podoplanin function in gliomas. Therefore we stably transfected two human glioma cell lines (U373MG and U87MG) with expression plasmids encoding podoplanin. The efficacy of transfection was confirmed by FACS analysis, PCR and immunocytochemistry. Cells were then sorted for highly podoplanin expressing cells (U373P(high)/U87P(high)). Transfection did not influence the production of pro-angiogenic factors including VEGF, VEGF-C and D. Also, expression of VEGF receptors (VEGFR) remained unchanged except for U87P(high), where a VEGFR3 expression was induced. U373P(high) showed significantly reduced proliferation as compared to mock transfected group. By contrast, podoplanin significantly increased migration and invasion into collagen matrix. Furthermore, conditioned media from P(high) glioma cells strongly induced tube formation on matrigel. In conclusion, podoplanin increased migration of tumor cells and enhanced tube formation activity in endothelial cells independent from VEGF. Thus, podoplanin expression may be an important step in tumor progression.

Entities:  

Keywords:  Podoplanin; angiogenesis; glioma

Mesh:

Substances:

Year:  2015        PMID: 26339454      PMCID: PMC4555782     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application.

Authors:  Clemens D Cohen; Karin Frach; Detlef Schlöndorff; Matthias Kretzler
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

2.  Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.

Authors:  Pavel Uhrin; Jan Zaujec; Johannes M Breuss; Damla Olcaydu; Peter Chrenek; Hannes Stockinger; Elke Fuertbauer; Markus Moser; Paula Haiko; Reinhard Fässler; Kari Alitalo; Bernd R Binder; Dontscho Kerjaschki
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

3.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

4.  Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.

Authors:  Kazuhiko Mishima; Yukinari Kato; Mika Kato Kaneko; Ryo Nishikawa; Takanori Hirose; Masao Matsutani
Journal:  Acta Neuropathol       Date:  2006-04-05       Impact factor: 17.088

5.  miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.

Authors:  Maria Angelica Cortez; Milena Sabrina Nicoloso; Masayoshi Shimizu; Simona Rossi; Gopal Gopisetty; Jennifer R Molina; Carlos Carlotti; Daniela Tirapelli; Luciano Neder; Maria Sol Brassesco; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Maria-Magdalena Georgescu; Wei Zhang; Vinay Puduvalli; George Adrian Calin
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

6.  Mutant IDH1 inhibits PI3K/Akt signaling in human glioma.

Authors:  Peter Birner; Stefan Pusch; Christo Christov; Stiliana Mihaylova; Kalina Toumangelova-Uzeir; Sevdalin Natchev; Sebastian F Schoppmann; Andrey Tchorbanov; Berthold Streubel; Jochen Tuettenberg; Marin Guentchev
Journal:  Cancer       Date:  2014-04-25       Impact factor: 6.860

7.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

8.  VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells.

Authors:  Ghazaleh Tabatabai; Caroline Herrmann; Gabriele von Kürthy; Michel Mittelbronn; Stefan Grau; Brigitte Frank; Robert Möhle; Michael Weller; Wolfgang Wick
Journal:  Brain       Date:  2008-08-09       Impact factor: 13.501

9.  Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.

Authors:  Yukinari Kato; Mika Kato Kaneko; Akiko Kunita; Hiromi Ito; Akihiko Kameyama; Satoshi Ogasawara; Nana Matsuura; Yasushi Hasegawa; Katsue Suzuki-Inoue; Osamu Inoue; Yukio Ozaki; Hisashi Narimatsu
Journal:  Cancer Sci       Date:  2007-10-18       Impact factor: 6.716

Review 10.  The potential role of podoplanin in tumour invasion.

Authors:  A Wicki; G Christofori
Journal:  Br J Cancer       Date:  2006-12-19       Impact factor: 7.640

View more
  15 in total

1.  Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.

Authors:  Tanja Eisemann; Barbara Costa; Patrick N Harter; Wolfgang Wick; Michel Mittelbronn; Peter Angel; Heike Peterziel
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

2.  Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.

Authors:  Yingjiao Xu; Wenjie Pang; Jishun Lu; Aidong Shan; Yan Zhang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

Review 3.  Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor-Tissue Interactions: A Review of Methods.

Authors:  Ivan V Chekhonin; Dimitry A Chistiakov; Nadezhda F Grinenko; Olga I Gurina
Journal:  Cell Mol Neurobiol       Date:  2018-05-10       Impact factor: 5.046

4.  Mechanical confinement triggers glioma linear migration dependent on formin FHOD3.

Authors:  Pascale Monzo; Yuk Kien Chong; Charlotte Guetta-Terrier; Anitha Krishnasamy; Sharvari R Sathe; Evelyn K F Yim; Wai Hoe Ng; Beng Ti Ang; Carol Tang; Benoit Ladoux; Nils C Gauthier; Michael P Sheetz
Journal:  Mol Biol Cell       Date:  2016-02-24       Impact factor: 4.138

Review 5.  Podoplanin in Inflammation and Cancer.

Authors:  Miguel Quintanilla; Lucía Montero-Montero; Jaime Renart; Ester Martín-Villar
Journal:  Int J Mol Sci       Date:  2019-02-06       Impact factor: 5.923

6.  PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma.

Authors:  Masahiro Shinada; Daiki Kato; Satoshi Kamoto; Sho Yoshimoto; Masaya Tsuboi; Ryohei Yoshitake; Shotaro Eto; Namiko Ikeda; Kohei Saeki; Yuko Hashimoto; Yosuke Takahashi; James Chambers; Kazuyuki Uchida; Mika K Kaneko; Naoki Fujita; Ryohei Nishimura; Yukinari Kato; Takayuki Nakagawa
Journal:  Cells       Date:  2020-05-05       Impact factor: 6.600

7.  Podoplanin Gene Disruption in Mice Promotes in vivo Neural Progenitor Cells Proliferation, Selectively Impairs Dentate Gyrus Synaptic Depression and Induces Anxiety-Like Behaviors.

Authors:  Ana Cicvaric; Hannah M Sachernegg; Tamara Stojanovic; Dörte Symmank; Tarik Smani; Thomas Moeslinger; Pavel Uhrin; Francisco J Monje
Journal:  Front Cell Neurosci       Date:  2020-01-15       Impact factor: 5.505

8.  Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment.

Authors:  Ji Yoon Lee; A-Reum Han; Sung-Eun Lee; Woo-Sung Min; Hee-Je Kim
Journal:  Mol Med Rep       Date:  2016-03-18       Impact factor: 2.952

9.  Cell motility and migration as determinants of stem cell efficacy.

Authors:  Lusine Danielyan; Matthias Schwab; Georg Siegel; Bianca Brawek; Olga Garaschuk; Nithi Asavapanumas; Marine Buadze; Ali Lourhmati; Hans-Peter Wendel; Meltem Avci-Adali; Marcel A Krueger; Carsten Calaminus; Ulrike Naumann; Stefan Winter; Elke Schaeffeler; Annett Spogis; Sandra Beer-Hammer; Jonas J Neher; Gabriele Spohn; Anja Kretschmer; Eva-Maria Krämer-Albers; Kerstin Barth; Hong Jun Lee; Seung U Kim; William H Frey; Claus D Claussen; Dirk M Hermann; Thorsten R Doeppner; Erhard Seifried; Christoph H Gleiter; Hinnak Northoff; Richard Schäfer
Journal:  EBioMedicine       Date:  2020-09-10       Impact factor: 8.143

10.  Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma.

Authors:  Chao Sun; Liming Xiao; Yuanlin Zhao; Jiankuan Shi; Yuan Yuan; Yu Gu; Feng Zhang; Xing Gao; Ying Yang; Risheng Yang; Junhui Qin; Jin Zhang; Chao Wang; Yingmei Wang; Zhe Wang; Peizhen Hu; Ting Chang; Liang Wang; Gang Wang; Huangtao Chen; Zhuyi Li; Jing Ye
Journal:  Transl Oncol       Date:  2020-03-21       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.